The utility of fetal fibronectin in asymptomatic singleton and twin pregnancies with a cervical length ≤ 10 mm

References

• Ananth CV, Goldenberg RL, Friedman AM, et al. Association of temporal changes in gestational age with perinatal mortality in the United States, 2007–2015. JAMA Pediatr. 2018;172(7):627–634.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Management of preterm labor. Obstet Gynecol. 2016;128(4):155–164.
   Google Scholar
• American College of Obstetricians and Gynecologists. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102–e109.
   Google Scholar
• Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320.
   PubMed Web of Science ®Google Scholar
• Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol. 1969;45(4):515–523.
   PubMed Web of Science ®Google Scholar
• Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.
   PubMed Web of Science ®Google Scholar
• Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177(1):13–18.
   PubMed Web of Science ®Google Scholar
• Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2016;215(4):431–438.
   PubMed Web of Science ®Google Scholar
• Berghella V, Hayes E, Visintine J, et al. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008;4(4):CD006843.
   Google Scholar
• Andersen HF, Nugent CE, Wanty SD, et al. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1990;163(3):859–867.
   PubMed Web of Science ®Google Scholar
• Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334(9):567–572.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Prediction and prevention of preterm birth. Obstet Gynecol. 2012;120(4):964–973.
   Google Scholar
• Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol. 2005;192(2):350–359.
   PubMed Web of Science ®Google Scholar
• Schmitz T, Maillard F, Bessard-Bacquaert S, et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol. 2006;194(1):138–143.
   PubMed Web of Science ®Google Scholar
• Adams TM, Kinzler WL, Chavez MR, et al. Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity. J Matern Fetal Neonatal Med. 2015;28(13):1598–1601.
   PubMed Web of Science ®Google Scholar
• Lotfi G, Faraz S, Nasir R, et al. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions. J Matern Fetal Neonatal Med. 2017;26:1–5.
   Google Scholar
• Wing DA, Haeri S, Silber AC, et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017;130(6):1183–1191.
   PubMed Web of Science ®Google Scholar
• Plaut MM, Smith W, Kennedy K. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms. Am J Obstet Gynecol. 2003;188(6):1588–93.
   PubMed Web of Science ®Google Scholar
• Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? a randomized trial. Am J Obstet Gynecol. 2004;191(1):235–240.
   PubMed Web of Science ®Google Scholar
• Lowe MP, Zimmerman B, Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol. 2004;190(2):358–362.
   PubMed Web of Science ®Google Scholar
• Lee GT, Burwick R, Zork N, et al. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times? J Matern Fetal Neonatal Med. 2013;26(7):706–709.
   PubMed Web of Science ®Google Scholar
• Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003;101(2):402–412.
   PubMed Web of Science ®Google Scholar
• Rozenberg P, Goffinet F, Malagrida L, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1997;176(1):196–199.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Das A, et al. The preterm prediction study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;182(3):636–643.
   PubMed Web of Science ®Google Scholar
• Sahasrabudhe N, Igel C, Echevarria GC, et al. Universal cervical length screening and antenatal corticosteroid timing. Obstet Gynecol. 2017;129(6):1104–1108.
   PubMed Web of Science ®Google Scholar
• Magro-Malosso E, Seravalli V, Cozzolino M, et al. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤20 mm. J Matern Fetal Neonatal Med. 2017;30(3):294–297.
   PubMed Web of Science ®Google Scholar
• Matthews KC, Gupta S, Lam-Rachlin J, et al. The association between fetal fibronectin and spontaneous preterm birth in twin pregnancies with a shortened cervical length. J Matern Fetal Neonatal Med. 2018;31(19):2564–2568.
   PubMed Web of Science ®Google Scholar
• Fox NS, Saltzman DH, Fishman A, et al. Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins. J Ultrasound Med. 2015;34(6):977–984.
   PubMed Web of Science ®Google Scholar
• Lifshitz SJ, Razavi A, Bibbo C, et al. Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit? J Matern Fetal Neonatal Med. 2014;27(6):566–570.
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides KH, Conde-Agudelo A, et al. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016;48(3):308–317.
   PubMed Web of Science ®Google Scholar
• Romero R, Conde-Agudelo A, El-Regaie W, et al. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017;49(3):303–314.
   PubMed Web of Science ®Google Scholar
• Macones GA. Fetal fibronectin testing in threatened preterm labor: time to stop. Am J Obstet Gynecol. 2016;215(4):405.
   PubMed Web of Science ®Google Scholar